Algert Global’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-22,484
Closed -$694K 1282
2023
Q3
$694K Buy
22,484
+13,370
+147% +$461K 0.03% 646
2023
Q2
$288K Buy
9,114
+550
+6% +$18.9K 0.01% 916
2023
Q1
$312K Sell
8,564
-4,233
-33% -$148K 0.01% 939
2022
Q4
$379K Sell
12,797
-2,040
-14% -$65.6K 0.02% 880
2022
Q3
$579K Buy
14,837
+6,667
+82% +$305K 0.04% 761
2022
Q2
$315K Buy
+8,170
New +$311K 0.02% 900

Other funds holding ASTH

Algert Global's ASTH Position: Q4 2023 in Review

Algert Global sold out of Astrana Health (ASTH) in Q4 2023, closing a stake of 22,484 shares — an estimated $694K sold.

Algert Global first reported a position in ASTH in Q2 2022 and held it in 6 quarters. The position peaked at $694K in Q3 2023. 143 funds tracked by Wall St. Rank hold ASTH as of Q4 2023.

  • Algert Global reported no remaining Astrana Health position as of Q4 2023 after selling out during the quarter.
  • Algert Global sold 22,484 Astrana Health shares in Q4 2023, an estimated $694K.
  • Algert Global first reported a position in Astrana Health in Q2 2022 and held it in 6 quarters.
  • Algert Global's Astrana Health position peaked at $694K in Q3 2023.
  • 143 funds tracked by Wall St. Rank held Astrana Health as of Q4 2023.

Based on Algert Global's 13F filing for Q4 2023, filed 14 Feb 2024.